Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00236197
Status:
COMPLETED
Last Update Posted:
2009-11-11
First Post:
2005-10-10
Brief Title:
E3810-A001-312 Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Study Overview
Official Title:
E3810-A001-312 Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the safety and efficacy of rabeprazole 10 mg in treating frequent heartburn
Detailed Description:
This is a multicenter double-blind randomized placebo-controlled study to investigate the safety and efficacy of rabeprazole 10 mg in treating frequent heartburn The study will last for up to five weeks and consists of the following three phases a one to two week screening period that includes a one week single-blind placebo run-in phase a two week double-blind randomized treatment phase and a one week single-blind placebo follow-up phase
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None